glp 1 receptor agonists are contraindicated in GLP-1 transforming metabolic care. Ophthalmologists now need to understand the ocular signals emerging around these drugs., The strongest safety discussion involves diabetic Emergency Presentations of GLP-1 Agonist

For cognitive impairment, FDA-approved options include donepezil and the newer anti-amyloid antibodies for Alzheimer disease

Dark Spots and Scar Reduction: Bid farewell to dark spots and scars with the power of this fast-acting whitening injection

Specificity and sensitivity of commercially available assays for glucagon-like peptide 1 (GLP-1): implications for GLP-1 measurements in clinical studies

Adjust dose, wait 1-2 weeks to assess, then consider other changes if needed

When switching from semaglutide to tirzepatide, your provider may recommend you follow the standard titration schedule and start at the lowest 2.5 mg dose of tirzepatide